| Drug Name |
Tenofovir |
| Drug ID |
BADD_D02154 |
| Description |
Tenofovir is an acyclic nucleotide diester analog of adenosine monophosphate.[A37693] In the most strict sense and due to the fact that it presents a phosphate group bound to the nitrogenous base, it is determined as an actual nucleotide analog.[A37693] The antiviral activities of tenofovir were first reported in 1993 and this agent was commercially available since 2008 in the form of [tenofovir disoproxil] and [tenofovir alafenamide] in order to obtain oral bioavailability.[A18473, A178360] |
| Indications and Usage |
Tenofovir has been shown to be effective against HIV, herpes simplex virus-2, and hepatitis B virus.[A178330]
To know more about the specific product indications, please visit the information in the orally available forms of tenofovir, [tenofovir alafenamide] and [tenofovir disoproxil]. |
| Marketing Status |
experimental; investigational |
| ATC Code |
J05AF07 |
| DrugBank ID |
DB14126
|
| KEGG ID |
D06074
|
| MeSH ID |
D000068698
|
| PubChem ID |
464205
|
| TTD Drug ID |
D0D9HW
|
| NDC Product Code |
Not Available |
| UNII |
99YXE507IL
|
| Synonyms |
Tenofovir | 9-(2-Phosphonylmethoxypropyl)adenine | 9-PMPA (tenofovir) | 9-(2-Phosphonomethoxypropyl)adenine | 9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer | 9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer | Tenofovir Disoproxil Fumarate | Disoproxil Fumarate, Tenofovir | Fumarate, Tenofovir Disoproxil | Tenofovir Disoproxil | Disoproxil, Tenofovir | 9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098 | (R)-9-(2-phosphonylmethoxypropyl)adenine | Viread |
